Clinical, virological and epidemiological aspects of acute B hepatitis in the Catania area (Italy);Virologica e clinica dell'epatite acuta B nella provincia di Catania

Infezioni in Medicina

Volumn 18, Issue 3, 2010, Pages 169-174

  Scalia, Guido ^a   Russo, Raffaela ^a   Palermo, Ilenia ^a   Gussio, Maria ^b   Bellissimo, Francesco ^b   Fatuzzo, Filippo ^a   Montineri, Arturo ^a   Patamia, Ildebrando ^a   Costanzo, Maria ^a   Zappalà, Daniela ^a   Russo, Rosario ^b   Cacopardo, Bruno ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acute hepatitis; Genotype; HBV; Mode of transmission

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN;

ACUTE HEPATITIS; ARTICLE; CLINICAL FEATURE; ESTHETIC SURGERY; HEALTH SURVEY; HEPATITIS B; INTRAVENOUS DRUG ABUSE; ITALY; MIGRATION; RISK FACTOR; SEXUAL TRANSMISSION; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BLOOD; BODY PIERCING; CHILD; DISEASE TRANSMISSION; FEMALE; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER FUNCTION TEST; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; SUBSTANCE ABUSE; TRAVEL; UNSAFE SEX; VIROLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY PIERCING; CHILD; EMIGRANTS AND IMMIGRANTS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; ITALY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SUBSTANCE ABUSE, INTRAVENOUS; TRAVEL; UNSAFE SEX; YOUNG ADULT;

EID: 78049453783     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. WHO/CDS/CSR/ LYO/2002.2: Hepatitis B. Available at: http://www.who.int/emc. accessed 17 July 2007
2. Mele A., Tosti M.E., Mariano A., et al., and National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin. Infect. Dis. 46 (6), 876-875, 2008.
3. Rantala M., van de Laar M.J. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill. 13 (21), 2008.
4. Marzano A., Angelucci E., Andreone P., et al., and Italian Association for the Study of the Liver. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig. Liver Dis. 39 (5), 397-408, 2007.
5. Gaeta G.B., Cuomo G. Epidemiologia delle epatiti virali in Italia. Ligand Assay 11 (4), 314-318, 2006.
6. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig. Liver Dis. 37 (8), 622-627, 2005.
7. Mele A., Spada E., Sagliocca L., et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J. Hepatol. 35, 284-289, 2001.
8. Wasley A., Grytdal S., Gallagher K., Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis-United States, 2006. MMWR Surveill Summ. 57 (2), 1-24, 2008.
9. Mele A., Tancredi F., Romanò L., et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J. Infect. Dis. 184 (7), 905-908, 2001.
10. Raimondo G., Isgrò G., Caccamo G., Pollicino T., Squadrito G., and the Calabrian HBV Study Group.. Is there a downgrading in the alert about the hepatitis B virus infection in Italy? Dig. Liv. Dis. 39, 257-261, 2007.
11. Koedijk F.D., op de Coul E.L., Boot H.J., van de Laar M.J. Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions. Ned Tijdschr Geneeskd. 151 (43), 2389-2394, 2007.
12. Mariano A., Mele A., Tosti M.E., et al. Role of beauty treatment in the spread of parenterally transmitted hepatitis Viruses in Italy. J. Med. Virol. 74 (2), 216-220, 2004.
13. Kalinina T., Riu A., Fischer L., et al. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 34 (2), 385-294, 2001.
14. Stroffolini T., Bianco E., Szklo A., et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2, 1246-1249, 2003.
15. Huang Y.W., Lin C.L., Chen P.J., Lai M.Y., Kao J.H., Chen D.S. Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B. Hepatogastroenterol. 55 (82-83), 633-635, 2008.
16. Liu H.G., Fan Z.P., Chen W.W., et al. A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients. Clin. Exp. Immunol. 151 (3), 441-447, 2008.
17. Schaefer S. Hepatitis B virus: significance of genotypes. J. Viral Hep. 12: 111-124, 2005.
18. Kikuchi K., Niitsuma H., Ishii M., et al. Genoepidemiology and its relationship to clinical features in patients infected chronically with hepatitis B virus (HBV). Hepatol Res 17, 43-55, 2000.
19. Kobayashi M., Arase Y., Ikeda K., et al. Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C. J. Gastroenterol. 37 (1), 35-39, 2002.
20. Kobayashi M., Arase Y., Ikeda K., et al. Clinical features of hepatitis B virus genotype A in Japanese patients. J. Gastroenterol. 38 (7), 656-662, 2003.
21. Sanchez-Tapias J.M., Costa J., Mas A., Bruguera M., Rodes J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123 (6), 1848-1856, 2002.